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Ischemic preconditioning represents an important adaptation mechanism of CNS, which
results in its increased tolerance to the lethal cerebral ischemia. The molecular mecha-
nisms responsible for the induction and maintenance of ischemic tolerance in the brain
are complex and not yet completely clarified. In the last 10 years, great attention has been
devoted to unravel the intracellular pathways activated by preconditioning and respon-
sible for the establishing of the tolerant phenotype. Indeed, recent papers have been
published supporting the hypothesis that mitochondria might act as master regulators
of preconditioning-triggered endogenous neuroprotection due to their ability to control
cytosolic calcium homeostasis. More interestingly, the demonstration that functional
alterations in the ability of mitochondria and endoplasmic reticulum (ER)managing calcium
homeostasis during ischemia, opened a new line of research focused to the role played
by mitochondria and ER cross-talk in the pathogenesis of cerebral ischemia in order
to identify new molecular mechanisms involved in the ischemic tolerance. In line with
these findings and considering that the expression of the three isoforms of the sodium
calcium exchanger (NCX), NCX1, NCX2, and NCX3, mainly responsible for the regulation
of Ca2+ homeostasis, was reduced during cerebral ischemia, it was investigated whether
these proteins might play a role in neuroprotection induced by ischemic tolerance. In
this review, evidence supporting the involvement of ER and mitochondria interaction
within the preconditioning paradigm will be provided. In particular, the key role played
by NCXs in the regulation of Ca2+-homeostasis at the different subcellular compartments
will be discussed as new molecular mechanism proposed for the establishing of ischemic
tolerant phenotype.
Keywords: ischemic preconditioning, sodium calcium exchanger, mitochondria, neurons, calcium
Introduction
Cerebral ischemia is a multifactorial and complex disease (1, 2). Indeed, the intracellular events
activated by the loss of perfusion of the brain and responsible for neuronal damage range from
impairment of intracellular homeostasis to mitochondrial dysfunction and free radical production
(3–5). The complexity of these events explains the great discrepancy between the frequency of
cerebral ischemic accidents and the lack of effective treatments able to inhibit or slow neuronal
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demise following the ischemic insult. Hence, the urgent need to
identify new potential targets for the development of innovative
therapeutic strategies able to defend the ischemic brain.
On these premises, in the recent years, the attention of the
researchers focused on ischemic tolerance a phenomenon, also
known as ischemic preconditioning (IPC), which consists of a
sub-lethal anoxic insult that makes the tissue in which it occurs
more resistant to a subsequent and potentially lethal ischemia
(6–11). The relevance of this phenomenon is to correlate to the
study of the endogenous mechanisms activated in neurons to
allow cell survival after a sub-lethal ischemic stimulus. By this way,
it is possible to identify new molecular targets useful to develop
alternative therapeutic strategies to treat the ischemic disease. The
great interest in the cerebral IPC and in the tolerance evoked by
itself also comes from the similarity of this phenomenon with
those clinical situations occurring in the human brain. Indeed, it
is well known that transient ischemic attacks (TIAs) do not cause
structural damage but appear to protect brain against a subsequent
“stroke” (12, 13).
Therefore, IPC or ischemic tolerance of the brain lie in a
natural adaptive process that can be mimicked by a variety of
sub-lethal insults, such as transient hypoxia, spreading depression,
oxidative stress, hyperthermia, or heat shock, and that increases
the tissue tolerance to a subsequent, potentially lethal ischemia.
This adaptive cytoprotection is a fundamental property of living
cells, which allows them to survive to the exposure to potentially
recurrent stressors. This phenomenonwas clearly identified in the
heart by Murry et al. (14) as preconditioning, or subsequently as
ischemic tolerance, and in 1990 it was described also in the brain
by Kitagawa et al. (15). Since then, it immediately attracted the
interest of clinical and basic neuroscientists for several reasons.
First, this biological process became widely recognized as a per-
tinent and effective experimental instrument to understand how
the brain protects itself against ischemia, thereby providing an
innovative approach for the discovery of novel neuroprotective
strategies. Second, retrospective case-control studies showed a
clinical correlate of the phenomenon discovered experimentally.
Molecular Mechanisms Involved in
Ischemic Preconditioning
Among the molecular mechanisms underlining ischemic toler-
ance, the substantial changes in gene expression play a crucial
role, suggesting that preconditioning is able to stimulate a genomic
reprograming of cells which in turn is responsible for the cytopro-
tection and cellular survival described in those tissues interested
by the ischemic event (16, 17). The effects in the cell genome,
occurring after IPC, represent the signature of the complex inter-
play of multiple signaling pathways. It is interesting to underline
that they are highly specialized pathways in different cell types
of the brain and concur to the cellular and systemic response
activated in the tissue to combat the noxious stimulus. Indeed,
it has been reported that hundreds of genes undergo upregula-
tion or downregulation in response to IPC stimuli (18–20), and
that these changes in gene expression differ between the harmful
ischemic insult and the sub-lethal IPC. In particular, precondi-
tioning seems to attenuate the response to ischemia (19), and the
tolerance established modifies the expression of genes involved in
the suppression of metabolic pathways, in the control of immune
responses, in the modulation of ion-channel activity, and in the
changes of blood coagulation parameters (19).
As recently reported, three phases, temporally consecutive of
the preconditioning phenomenon have been identified as induc-
tion, transduction, and tolerance.
Induction and transduction mechanisms
of tolerance
The induction of tolerance requires that the preconditioning stim-
ulus has to be recognized by molecular sensors as a sign of a
more severe phenomenon that will occur. This implicated the
identification of numerous types of sensors, including neuro-
transmitters, neuromodulators, cytokines, and toll-like receptors
(21) as well as ion channels and redox-sensitive enzymes (22–
24) which in turn will activate subsequent transduction pathways
responsible for initiating the adaptive response. The activation
of the transduction phase also implies the involvement of dif-
ferent transducers depending, at least in part, on the nature of
the preconditioning stimulus. They include members of mitogen-
activated protein kinases (MAPKs) and their phosphorylated Ras,
Raf, MEK, and ERK subfamilies (7, 22, 24, 25); mitochondrial
ATP-sensitive K+ (KATP) channels (26, 27) Akt (28–31); and the
protein kinase C-" isoform (32). The possibility that the nitric
oxide (NO)-based adaptive response to hypoxia in Drosophila
(33) is evolutionarily conserved suggests that this multifunc-
tional modulator might be a logical choice as an autocrine and
paracrine mediator of preconditioning stress. Indeed, pharmaco-
logical and genetic evidence supporting the involvement of NO
in the transduction process is continuing to mount. As matter of
fact, it has been reported that NO can exert a neuroprotective role
during preconditioning (7, 34), and we have recently proposed
that NO-induced neuroprotection is associated to preservation
of mitochondrial function (24). On the other hand, precondi-
tioning positively affects the integrity of mitochondrial oxidative
phosphorylation after cerebral ischemia, an effect restricted to
the delayed window of preconditioning (35). Moreover, precon-
ditioning prevents mitochondrial swelling, preserves membrane
integrity fluidity, and protects mitochondrial energy metabolism
during cerebral ischemia avoiding ATP consumption (36).
Given the redox sensitivity of many of those above-mentioned
kinases and transcription factors, reactive oxygen species might
also be contemplated within transducers (37–39). Furthermore,
adenosine, another prototypical paracrine mediator and “retal-
iatory metabolite,” whose production is linked to ATP degrada-
tion, might be considered a transducer responsible for tolerance
induction, in some in vitro and in vivomodels (26, 27, 40, 41).
It is worth of note that although in general, mitochondria
have been considered important mediators of endogenous neu-
roprotection, the mechanisms by which they might “integrate”
cytoprotective signaling of preconditioning remain to be fully
elucidated.
Role of mitochondria in ischemic tolerance
It is well known thatmitochondria are also able to sense and shape
cytosolic Ca2+ signals by taking up and subsequently releasing
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Ca2+ ions during physiological and pathological Ca2+ elevations
(42). Mitochondrial function is strictly dependent on maintain-
ing of mitochondrial calcium homeostasis. In fact, thanks to the
activity of Ca2+-sensitive mitochondrial dehydrogenases these
organelles can regulate oxidative phosphorylation and ATP syn-
thesis during conditions of high cellular demand (43). There-
fore, to explore the relationship between mitochondrial oxidative
capacity and calcium buffering activity during IPC might repre-
sent an attractive strategy mediating neuroprotection in ischemic
conditions. In particular, considering that the influence of Ca2+ in
the regulation of mitochondrial function is highly dependent on
the spatiotemporal distribution of [Ca2+]i (44, 45), the assump-
tion that during IPC an interaction between mitochondria and
ER might affect mitochondrial metabolic properties, and in turn
neuronal survival has been also investigated (31). This hypothesis
is supported by the concept that microdomains of high [Ca2+]i
have been identified near Ca2+ channels on the plasmamembrane
and ER (46).
Cellular Ionic Homeostasis and Energy
Metabolism During Ischemic
Preconditioning
It has beenwidely described that IPC activates intracellular biolog-
ical responses prior to a potential lethal insult (17, 47–49), and that
these events make the tissue in which they occur more resistant to
the subsequent severe ischemia (17, 47, 50–52). In this regard, it
is possible to speculate that an increase of energy metabolism or a
latency in anoxic depolarization following the onset of ischemic
insult might represent one of the mechanisms by which tissues
strengthen their tolerance when exposed to a sub-lethal insult.
Indeed, it has been reported that a reduction in energy demand
and in the activity of ion channels represents determinant fac-
tors for ischemic tolerance establishment (19, 53, 54). To this
aim, in vitro experiments performed in cortical neurons demon-
strated that the exposure to brief non-injurious oxygen and glu-
cose deprivation (OGD) causes an impairment in voltage-gated
potassium channels (55). Similarly, the impairment of Na+/K+-
ATPase activity occurring in rat hippocampal and cortical neu-
rons exposed to global forebrain ischemia is counteracted by IPC
(56). Interestingly, in the last years, it has been shown that some
integral plasma membrane proteins, involved in the control of
Ca2+ andNa+ ion influx or efflux, the sodiumcalciumexchangers
(NCXs) might function as crucial players in the pathogenesis of
brain ischemic damage (57). Therefore, these proteins, by regu-
lating Na+ and Ca2+ homeostasis, may represent more suitable
molecular targets for therapeutic intervention in ischemic stroke.
Asmatter of fact, in vivo experiments performed in gerbils demon-
strated that during IPC, an increase in Ca2+-ATPase activity and
an enhancement in mitochondrial calcium sequestration occur
in CA1 hippocampal neurons (47). In line with this findings,
intracellular calcium measurements in hippocampal neurons of
preconditioned gerbils showed that the increase in [Ca2+]i occur-
ring after anoxic and aglycemic episodes was markedly reduced
in the ischemic tolerant animals (58). However, the molecular
mechanisms responsible for this effect are still matter of debate
and not completely clarified. As recently proposed by Kato et al.
(59), a possible explanation could be related to the increased
expression of the Ca2+-ATPase isoform 1 [plasma membrane
calcium ATPase 1 (PMCA-1)]. Moreover, considering that mito-
chondria play a crucial role in the regulation of intracellular Ca2+
homeostasis due to their high capacity to sequestrate Ca2+ both
in physiological and in pathological conditions, they have been
included among the possible intracellular mechanisms triggered
by preconditioning stimuli. Indeed, although it is widely reported
that the excessive amount of Ca2+, as it occurs during ischemia,
causes an impairment of mitochondrial function with consequent
massive uncoupling of oxidative phosphorylation, mitochondrial
depolarization and mitochondrial permeability transitional pore
(MPTP) opening, reversal of the action of ATP synthase and cell
death, and studies performed both in the heart and in the brain
demonstrated that the inhibition of MPTP opening and its signal-
ing cascade represent crucial events responsible for cytoprotection
observed in IPC (53, 60). What are the molecular mechanisms
underlining these effects is still object of investigation. Among
them, nitrite and protein kinases have been proposed as possible
MPTP regulators (61–64) Table 1.
More interestingly, the hypothesis that a modulation of the
expression and activity of the NCXs might have a role in the
regulation of calcium and sodium homeostasis during ischemic
tolerance has been recently suggested (31, 50, 71). This might
be relating to the ability of Na+/Ca2+ exchanger to work in
concert with selective ion channels and ATP-dependent pumps,
in maintaining the physiological cytosolic concentrations of these
two ions (72).
NCXs functional properties in ischemic brain
In the brain, unlike other tissues, NCX is present in three dif-
ferent gene products, named NCX1, NCX2, and NCX3, with a
TABLE 1 |Mitochondrial effectors of preconditioning-induced
neuroprotection.
Type of
study
Species Stimulus Mechanism Reference
In vivo Rat Ischemic Energy metabolism and
mitochondrial function
(35)
(65)
In vitro Hippocampal
neurons
Ischemia Mitochondrial
ATP-dependent
potassium channel
(66)
In vivo Rat
In vivo Mouse Hypoxia GLUT-1 (18, 63)
Rat (67)
In vivo Rat Normobaric
Hypoxia
Phosphofructokinase and
LDH
(67)
In vivo Rat Ischemia Calcium/calmodulin-
dependent protein
kinase II
(68, 69)
In vivo Gerbil Ischemia Akt/protein kinase B (28)
In vivo Rat Ischemia mitogen-activated protein (70)
In vitro Cortical
neurons
Hypoxia NCX3 (31)
In vitro Cortical
neurons
Hypoxia MnSOD (24)
In vivo Rat Ischemia (23)
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distinct distribution pattern in different brain regions (73). Under
physiological conditions, NCX works primary extruding Ca2+
in response to a depolarization or to an increase in intracellular
Ca2+ concentrations coupled to receptor stimulation (74). How-
ever, during hypoxic conditions, when the dysfunction of the two
plasma membrane ATP-dependent pumps Na+/K+ ATPase and
Ca2+ ATPase occurs, NCX assumes a relevant role in control-
ling the intracellular homeostasis of these two cations, since it is
able to operate promoting Na+ ions extrusion and Ca2+ influx
(74, 75). Although this reverse mode of operation in the early
phase of anoxia does undoubtedly elicit an increase in [Ca2+]i,
its effect could be beneficial for neurons because it contributes to
decrease [Na+]i overload, a phenomenon which would otherwise
lead to cell swelling and thus to sudden necrotic neuronal death.
Conversely, in the later phase of neuronal anoxia, when [Ca2+]i
overload takes place, NCX working in the forward mode of oper-
ation can contribute to the lowering of Ca2+ concentrations, and
thus it can protect neurons from intracellular Ca2+overload, neu-
rotoxicity, and subsequent cell death (74). As we recently demon-
strated, NCX1, NCX2, and NCX3may exert different roles during
in vitro and in vivo anoxic conditions leading to a new paradigm
in the pathogenesis of ischemic damage. Indeed, we provided
evidences that in cells singly and stably transfected with NCX3,
this isoform contributes more significantly to the maintenance of
[Ca2+]i homeostasis during experimental conditions mimicking
ischemia, thereby preventing mitochondrial ∆Ψ collapse and cell
death (76). This is due to a different sensitivity of the three NCX
isoforms to the changes in ATP content occurring during anoxia.
Indeed, NCX3 results more resistant to ATP changes compared
to NCX1 and NCX2 (76). In addition, in in vivo experiments, the
selective knocking down ofNCX1 andNCX3, but not ofNCX2, by
antisense oligodeoxynucleotide strategy (57) or the disruption of
the ncx3 gene, renders the brain more susceptible to the ischemic
insult (77).Moreover, the induction of permanentmiddle cerebral
artery occlusion in rats correlates with NCX1 mRNA upregula-
tion in the peri-infarct area thus suggesting the possibility that
this isoform could be a new druggable target for the treatment
of cerebral ischemia. In line with this hypothesis, we recently
demonstrated that NCX1 transcript and protein were upregulated
by ischemic cerebral preconditioning. This effect was mediated
by the transcriptional factor HIF1α and was accompanied by a
relevant neuroprotection (71).
Role of NCX1 and NCX3 in the ischemic
preconditioning
Recent findings demonstrated that the two isoforms of the
Na+/Ca2+ exchanger, NCX1 and NCX3, which are involved in
several pathophysiological aspects of cerebral ischemia, can be
included among the members of the growing family of the media-
tors involved in the ischemic brain tolerance due to their ability to
regulate neuronal calcium homeostasis (Figure 1). In particular,
we provide evidence that neuroprotection observed in precon-
ditioned neurons exposed to OGD/reoxygenation is correlated
to the increase in NCX1 and NCX3 protein expression. Indeed,
the treatment with siRNA against NCX1 and NCX3 prevents this
effect. These data are in accordance with results recently observed
in vivo in an animal model of IPC (50). Consistently with these
results, the upregulation of NCX1 and NCX3 protein expression
in neurons exposed to IPC was dependent on PI3K/Akt acti-
vation, since the treatment with LY294002 was able to abolish
this increase. Interestingly, we demonstrated that NO plays a
key role in the triggering PI3K/Akt pathway as the increase in
the phosphorylated form of Akt observed within 30min after
IPC was completely abolished by the treatment with L-NAME.
More importantly, the treatment with L-NAMEwas able to inhibit
NCX3 but did not affect NCX1 protein expression (31).
Calcium Homeostasis in ER and
Mitochondria During Ischemic
Preconditioning
It has recently demonstrated that in neuronsNCX3, apart its local-
ization on the plasma membrane, is also expressed on the outer
mitochondrial membrane where it contributes to the extrusion
of calcium from mitochondria (78). It is well known that mito-
chondria, in addition to the generation of cellular energy, play an
important role in regulating cellular calcium homeostasis (79–82)
in concert with the sarco-endoplasmic reticulum Ca2+-ATPase
(SERCA), the plasma membrane Ca2+-ATPase, and Na+/Ca2+
exchanger (83). On the other hand, themaintenance of mitochon-
drial calcium homeostasis is an important requirement ensuring
mitochondrial function. In fact, Ca2+-sensitive dehydrogenases
can regulate oxidative phosphorylation and ATP synthesis during
times of high cellular demand (43). Therefore, it is possible to
hypothesize that the increased expression of NCX3, we observed
within 48 h from the sub-lethal insult,might exert neuroprotective
effects regulating calcium handling and improving mitochondrial
oxidative capacity. This finding is in line with the results pre-
viously obtained in an in vitro model of IPC and demonstrat-
ing that the increase in nNOS expression and NO production
through the activation of Ras/ERK1/2 pathway stimulated mito-
chondrial MnSOD. These effects associate with a reduction in
free radical production and cytocrome c release from mitochon-
dria to cytosol, and in turn with an improvement of neuronal
survival (24). The demonstration that NCX3 might represent
a target of IPC-induced neuroprotection (31) adds new insight
into the molecular mechanisms involved in the ischemic brain
preconditioning. Indeed, the over-expression of NCX3might help
mitochondria to preserve their energetic capacity making them
less vulnerable to the subsequent lethal insult represented by
OGD/reoxygenation. This hypothesis was strongly supported by
the results obtained measuring the activity of NCX during IPC.
In fact, we demonstrated that IPC induced an increase of NCX
activity in the reverse mode of operation that was still observed in
preconditioned neurons exposed to OGD/Reoxygenation. This is
an early event since it occurred within 30min after IPC stimulus
was due to the contribution of NCX1 and NCX3 isoforms and
was promoted by NO because it was abolished by the treatment
with L-NAME. Intriguingly, this effect was associated with an
increase in ER calcium content. Consistently with data previously
published in our Laboratory (84), we speculated that NCX1,
working in the reverse mode of operation, plays a key role in
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FIGURE 1 | Effect of ischemic preconditioning on cytosolic and
mitochondrial calcium content in cortical neurons exposed to OGD.
Confocal images showing in red mitochondrial Ca2+ content measured by
XRhod-1 probe (200 nM, 15min at RT) and in green cytosolic calcium
concentration measured by Fluo 3 AM probe (5µM, 30min at RT).
(A–C): cortical neurons under control conditions (CTL); (D–F): cortical
neurons exposed to 30min of oxygen and glucose deprivation (OGD),
preconditioning stimulus (PC); (G–I): cortical neurons exposed to 3 h
OGD; (J-L): preconditioned neurons exposed to OGD (PC+OGD).
Scale bars: 1µm.
the regulation of ER calcium refilling in the early phase of IPC
(Figure 2). Indeed, the treatment with siNCX1, but not siNCX3,
was able to prevent this phenomenon. The novel aspect of the
study is the demonstration that NO promoted NCX1-induced
ER refilling that was hampered by L-NAME pretreatment. This
finding is in accordance with data recently published by Secondo
et al. and demonstrating that NO was able to stimulate NCX1
to work in the reverse mode of operation, whereas NO did not
affect NCX3 activity (85). The possibility that NCX1 activation in
the early phase of IPC could affect mitochondrial calcium content
promoting mitochondrial calcium uptake could not be excluded.
However, in the late phase of IPCmitochondrial calcium handling
ismainly regulated byNCX3 that is able to promotemitochondrial
calcium extrusion (Figure 2). These data are supported by the
finding that NCX3 expression increased 48 h after the IPC insult
(31). We have previously demonstrated that NCX3 is distributed
also atmitochondrial level; therefore, it is possible to speculate that
during IPC, the increased expression of NCX3 on mitochondria
might contribute to the efflux of calcium from the organelle
thus protecting neurons by the subsequentmitochondrial calcium
overload induced by lethal OGD/reoxygenation exposure. The
finding that the treatmentwithCGP and siNCX3 counteracted the
effect of IPC onmitochondrial calcium content, leading to the lack
of IPC-neuroprotection, further supports this hypothesis (31).
Collectively, we can conclude that a functional interplay between
NCX1 and NCX3 occurs during IPC. This phenomenon is tightly
dependent on NO and Akt activation, and by contributing to the
modulation of intracellular ionic homeostasis, could represent one
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FIGURE 2 | Schematic model of preconditioning-induced
neuroprotection. Preconditioning stimulus activates neuronal nitric oxide
synthase (nNOS) to produce NO which in turn stimulates plasma membrane
NCX1 activity in the reverse mode of operation and promotes endoplasmic
reticulum (ER) refilling in the early phase of PC. NO activate PI3K/Akt pathway,
which increases the expression and activity of plasma membrane and
mitochondrial NCX3, thus promoting mitochondrial calcium efflux in the late
phase of preconditioning. These mechanisms working in concert promote
neuronal survival. PI3K: phosphatidylinositol-3-kinases; CREB: cAMP response
element-binding protein; SERCA: sarco/ER Ca2+-ATPase; IP3R: inositol
trisphosphate receptor; MCU: mitochondrial calcium uniporter; VDAC:
voltage-dependent anionic channel; NCLX: Na+/Ca2+ exchanger
Li-dependent; HCX: Ca2+/H+ exchanger; PTP: permeability transition pore;
OMM: outer mitochondrial membrane; IMM: inner mitochondrial membrane.
of the mechanisms responsible for neuroprotection induced by
IPC (Figure 2).
Conclusion
The experimental data described in this review support the
hypothesis that mitochondria play a pivotal role in neuroprotec-
tive events provided by preconditioning. Indeed, both the mito-
chondrial antioxidant enzyme MnSOD and the proteins involved
in the regulation of mitochondrial calcium homeostasis, such
as mNCX3, represent new targets and mediators involved in
preconditioning-induced neuroprotective responses. This is in
line with the results reported in the literature that “mitochondrial
preconditioning” has many neuroprotective effects, both during
and following neurotoxic insults, including an improvement of
neuronal viability, the attenuation of the intracellular Ca2+ influx,
the suppression of ROS generation, the inhibition of apoptosis,
and themaintenance of ATP levels (86). Therefore, understanding
the precise mitochondrial mechanisms involved in precondition-
ing will provide important information necessary to develop new
and more effective therapeutic strategies for neurodegeneration
occurring in brain ischemia. In this regards, the identification of
NCX3 as new player in the regulation of mitochondrial calcium
efflux and the demonstration that an increase in its expression
occurs during preconditioning, promotingmitochondrial calcium
homeostasis, might help to draw new therapeutic strategy poten-
tially able to delay neuronal loss occurring in ischemia. More
interestingly, the demonstration that an increase in NCX1 and
NCX3 activity is responsible for Ca2+ cycling from ER and mito-
chondria, and proof that it activates intracellular events leading to
neuroprotection observed in IPC support this hypothesis (31). In
this scenario, the identification of a compound able to selectively
stimulate the activity of NCX1 and to prevent neuronal degener-
ation in in vitro and in vivomodels of ischemia has been recently
synthesized (77). Moreover, compounds able to stimulate NCX3
activity are in progress of development in our Laboratory.
Therefore, based on this early observation, these studies
have potentially revealed new molecular targets in cerebral
ischemia and neurodegenerative diseases pathogenesis, which
ultimately may open up alternative avenues for future therapeutic
intervention.
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